Skip to main content
Figure 3 | BMC Endocrine Disorders

Figure 3

From: Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years

Figure 3

Improvements in body weight, blood pressure, and serum lipids. A) LS mean ± SE changes in body weight at 2 years for the ITT (N = 295) and completer populations (N = 216). B) Reductions in both body weight and A1C in the completer population after 104 weeks. C) LS mean change from baseline ± SE in systolic blood pressure (SBP) after 104 weeks of treatment, further analyzed by normal or abnormal baseline SBP, in the completer population (N = 216; Normal baseline, n = 113; Abnormal baseline, n = 103) and ITT population (All, N = 295; Normal baseline, n = 158; Abnormal baseline, n = 137). D) Changes in serum lipids were seen at week 104 (completer and IIT populations): data are presented as LS mean ± SE for all lipids except for triglycerides (geometric LS mean percent change ± SE from baseline).

Back to article page